Takara Bio (FRA:TF2) Long-Term Debt: €54.5 Mil (As of Mar. 2026)


FRA:TF2 Takara Bio Inc FRA:TF2
50 GF Score
Price €5.95
GF Value €4.47
! 6 Warning Signs
View Full Analysis

What is Takara Bio Long-Term Debt?

Takara Bio FRA:TF2 50 Long-Term Debt is €54.5 Mil as of Mar. 2026. GuruFocus rates FRA:TF2 with a GF Score™ of 50/100 and a GF Value™ of €4.47. The stock has 6 warning signs investors should review.

Takara Bio's Long-Term Debt for the quarter that ended in Mar. 2026 was €54.5 Mil.

Takara Bio's quarterly Long-Term Debt declined from Sep. 2025 (€57.6 Mil) to Dec. 2025 (€54.8 Mil) and declined from Dec. 2025 (€54.8 Mil) to Mar. 2026 (€54.5 Mil).

Takara Bio's annual Long-Term Debt stayed the same from Mar. 2024 (€0.0 Mil) to Mar. 2025 (€0.0 Mil) but then increased from Mar. 2025 (€0.0 Mil) to Mar. 2026 (€54.5 Mil).

Takara Bio  (FRA:TF2) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Takara Bio Long-Term Debt Related Terms

Takara Bio Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Takara Bio's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Takara Bio Long-Term Debt Chart

Takara Bio Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 54.51

Takara Bio Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 57.62 54.77 54.51
FRA:TF2
50GF Score
Takara Bio Inc FRA:TF2
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of €54.5 Mil mean?
Takara Bio (FRA:TF2) has a Long-Term Debt of €54.5 Mil as of Mar. 2026.
Is Takara Bio's Long-Term Debt too high?
Takara Bio's current Long-Term Debt is €54.5 Mil. Overall, Takara Bio has a GF Score™ of 50/100, reflecting its overall financial health beyond just this single metric.
How does Takara Bio's Long-Term Debt compare to VRTX and REGN?
Takara Bio's Long-Term Debt of €54.5 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Biotechnology company?
A good Long-Term Debt depends on the Biotechnology industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Takara Bio's current Long-Term Debt is €54.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Takara Bio stock overvalued right now?
Takara Bio (FRA:TF2) has a current Long-Term Debt of €54.5 Mil. The stock's GF Value™ is €4.47, compared to a current price of €5.95 — trading 33.1% above its estimated fair value. The current Long-Term Debt is €54.5 Mil. Takara Bio's overall GF Score™ is 50/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Takara Bio (FRA:TF2), the current Long-Term Debt is €54.5 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Takara Bio (FRA:TF2) Overvalued in 2026?

Based on GuruFocus' analysis, Takara Bio stock appears to be overvalued. The current stock price of €5.95 is trading 33.1% above its estimated GF Value™ of €4.47.

Key valuation signals for FRA:TF2:

  • Long-Term Debt: €54.5 Mil
  • GF Value™: €4.47 vs. price of €5.95 (33.1% above fair value)
  • GF Score™: 50/100 with 6 warning signs

No single metric tells the full story. See the FRA:TF2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Takara Bio Business Description

Other Exchanges 4974:Japan
Address Nojihigashi 7-4-38 Kusatu, Shiga, Otsu, JPN, 520-0058
Takara Bio Inc is a biotechnology company that develops gene therapy procedures. The company reports in three business segments: Bioindustry, Gene therapy, and AgriBio. Takara's bioindustry business provides research reagents, scientific instruments, and various contracted services to universities and companies around the world. The company's gene therapy business is focused on treating cancer and HIV. Its AgriBio business aims to leverage biotechnologies in the food ingredient field, including large-scale mushroom production. The vast majority of Takara's revenue is derived from its bioindustry segment.
50GF Score

Get the complete analysis for FRA:TF2

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.95
Price
€4.47
GF Value